Patent Landscape and Market Research Report Artificial Blood Substitutes

1. Patent Landscape and Market Research Report Patent Landscape and Market Research Report Artificial Blood Substitutes Artificial Blood Substitutes Patent Landscape and Market Research Report on Artificial Blood Substitutes aims to present business and patent landscape for the emerging market of artifiical blood substitutes.The objective of this patent landscape report is to analyze existing technologies and emerging trends in artificial blood substitute technology patent activity. The observed patterns have been used to provide critical technology insight. Patent density in this domain was determined using various correlation matrix. R&D interest in artificial blood products technologies has maintained at a constant pace with approximately 67 patents filed every year over the period from 1997 to 2016. The study presents a detailed analysis of research activities in Artificial blood substitutes industry along with significant patent data trends and analysis. Artificial blood products market has been analyzed based on various attributes and attempts to segment the market based on - First, by Source (human blood, animal blood, microorganism based recombinant Hb, synthetic polymers, stem cells) from which blood substitutes are derived. Second, by Product type (PFCs, HBOCs). Third, by Application (Cardiovascular diseases, Malignant neoplasms, Injuries, Neonatal Conditions, Organ transplants, Maternal condition. Forth, by Patent Activities (patent categories and classification, patent landscape analysis, licensing and litigation).

2. Six potential application markets have been identified based on the possibility of replacing donor blood in critical medical treatments: •Injuries •Cardiovascular diseases •Malignant neoplasms •Neonatal Conditions •Organ transplants •Maternal condition Number of artificial blood units required for blood transfusion in each of the six categories of medical treatment cases have been assumed based on the current average number of donor blood units used for transfusion procedures in these categories. This patent analysis will provide insights into the market growth of artificial blood substitutes concerning diverse applications and strategical positioning of key players. Key players are endeavoring to win a significant share of the market through new production methodologies, front-line advancements, and new items. It will also reveal the dominance by US companies over other regional players in most of the application sectors. Companies like Alliance Pharmaceutical Corp., Baxter Healthcare Corp., Nuvox Pharmaceuticals, Sanguine Inc., and Therapure Biopharma are the active palyers in the artificial blood products market. Competitive landscape has been prepared by profiling the key players in the global artificial blood substitute market. Current development stages of the products of the profile companies have also been included. Excluded from consideration are individual product description, detailed and unpublished clinical/lab results on the products, and exact methodology/techniques used for product production. Table of content Executive Summary Chapter 1 Introduction Chapter 2 Technology Overview Chapter 3 Business Landscape and Forecast Chapter 4 Market Trends and Challenges Chapter 5 Competitive Landscape Chapter 6 Innovation Landscape Chapter 7 Appendix Table of Tables Table of Figures About Ahead Intelligence To know more about the detailed TOC and Free Sample pdf visit - Artificial Blood Substitute Market Report by Ahead Intelligence